We bring you the latest news from the healthcare about the health care in the United Kingdom. Do your have news for us? Contact the editor. Watch also this special movie.

donderdag 9 februari 2017

Oncogene - Table of Contents alert Volume 36 Issue 6

If you are unable to see the message below, click here to view.
Oncogene

Advertisement

Think ChIP is hard?

We make it easy!

  • ChIP and ChIP-seq - easy kits, even for beginners.
  • Validated ChIP antibodies - they work the first time! 
  • Bioruptor chromatin shearing systems - cited over 2,000 times. 
  • ChIP/ChIP-seq automation
       Learn more
 

TABLE OF CONTENTS

Volume 36, Issue 6 (February 2017)

In this issue
Original Articles
Corrigendum

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Original Articles

Top

microRNAs with AAGUGC seed motif constitute an integral part of an oncogenic signaling network OPEN

Y Zhou, O Frings, R M Branca, J Boekel, C le Sage, E Fredlund, R Agami and L M Orre

Oncogene 2017 36: 731-745; advance online publication, August 1, 2016; 10.1038/onc.2016.242

Abstract | Full Text

Loss of BRCA1 or BRCA2 markedly increases the rate of base substitution mutagenesis and has distinct effects on genomic deletions OPEN

J Zámborszky, B Szikriszt, J Z Gervai, O Pipek, Á Póti, M Krzystanek, D Ribli, J M Szalai-Gindl, I Csabai, Z Szallasi, C Swanton, A L Richardson and D Szüts

Oncogene 2017 36: 746-755; advance online publication, July 25, 2016; 10.1038/onc.2016.243

Abstract | Full Text

Inhibition of MAPK pathway is essential for suppressing Rheb-Y35N driven tumor growth

Y Wang, X Hong, J Wang, Y Yin, Y Zhang, Y Zhou, H-l Piao, Z Liang, L Zhang, G Li, G Xu, D J Kwiatkowski and Y Liu

Oncogene 2017 36: 756-765; advance online publication, July 11, 2016; 10.1038/onc.2016.246

Abstract | Full Text

EWS-FLI1-mediated suppression of the RAS-antagonist Sprouty 1 (SPRY1) confers aggressiveness to Ewing sarcoma

F Cidre-Aranaz, T G P Grünewald, D Surdez, L García-García, J Carlos Lázaro, T Kirchner, L González-González, A Sastre, P García-Miguel, S E López-Pérez, S Monzón, O Delattre and J Alonso

Oncogene 2017 36: 766-776; advance online publication, July 4, 2016; 10.1038/onc.2016.244

Abstract | Full Text

Endogenous GABAA receptor activity suppresses glioma growth

A Blanchart, R Fernando, M Häring, N Assaife-Lopes, R A Romanov, M Andäng, T Harkany and P Ernfors

Oncogene 2017 36: 777-786; advance online publication, July 4, 2016; 10.1038/onc.2016.245

Abstract | Full Text

FBW7 mutations mediate resistance of colorectal cancer to targeted therapies by blocking Mcl-1 degradation

J Tong, S Tan, F Zou, J Yu and L Zhang

Oncogene 2017 36: 787-796; advance online publication, July 11, 2016; 10.1038/onc.2016.247

Abstract | Full Text

Overproduction of IGF-2 drives a subset of colorectal cancer cells, which specifically respond to an anti-IGF therapeutic antibody and combination therapies

H Zhong, C Fazenbaker, C Chen, S Breen, J Huang, X Yao, P Ren, Y Yao, R Herbst and R E Hollingsworth

Oncogene 2017 36: 797-806; advance online publication, July 11, 2016; 10.1038/onc.2016.248

Abstract | Full Text

A novel FOXM1 isoform, FOXM1D, promotes epithelial–mesenchymal transition and metastasis through ROCKs activation in colorectal cancer OPEN

X Zhang, L Zhang, Y Du, H Zheng, P Zhang, Y Sun, Y Wang, J Chen, P Ding, N Wang, C Yang, T Huang, X Yao, Q Qiao, H Gu, G Cai, S Cai, X Zhou and W Hu

Oncogene 2017 36: 807-819; advance online publication, July 11, 2016; 10.1038/onc.2016.249

Abstract | Full Text

TRIP12 as a mediator of human papillomavirus/p16-related radiation enhancement effects

L Wang, P Zhang, D P Molkentine, C Chen, J M Molkentine, H Piao, U Raju, J Zhang, D R Valdecanas, R C Tailor, H D Thames, T A Buchholz, J Chen, L Ma, K A Mason, K-K Ang, R E Meyn and H D Skinner

Oncogene 2017 36: 820-828; advance online publication, July 18, 2016; 10.1038/onc.2016.250

Abstract | Full Text

Synergistic functions of E2F7 and E2F8 are critical to suppress stress-induced skin cancer OPEN

I Thurlings, L M Martínez-López, B Westendorp, M Zijp, R Kuiper, P Tooten, L N Kent, G Leone, H J Vos, B Burgering and A de Bruin

Oncogene 2017 36: 829-839; advance online publication, July 25, 2016; 10.1038/onc.2016.251

Abstract | Full Text

Downregulation of CXCL12 in mesenchymal stromal cells by TGFβ promotes breast cancer metastasis OPEN

P F Yu, Y Huang, C L Xu, L Y Lin, Y Y Han, W H Sun, G H Hu, A B Rabson, Y Wang and Y F Shi

Oncogene 2017 36: 840-849; advance online publication, September 26, 2016; 10.1038/onc.2016.252

Abstract | Full Text

FoxF1 and FoxF2 transcription factors synergistically promote rhabdomyosarcoma carcinogenesis by repressing transcription of p21Cip1 CDK inhibitor

D Milewski, A Pradhan, X Wang, Y Cai, T Le, B Turpin, V V Kalinichenko and T V Kalin

Oncogene 2017 36: 850-862; advance online publication, July 18, 2016; 10.1038/onc.2016.254

Abstract | Full Text

Elevated hydrostatic pressure enhances the motility and enlarges the size of the lung cancer cells through aquaporin upregulation mediated by caveolin-1 and ERK1/2 signaling

Y-C Kao, J-R Jheng, H-J Pan, W-Y Liao, C-H Lee and P-L Kuo

Oncogene 2017 36: 863-874; advance online publication, August 8, 2016; 10.1038/onc.2016.255

Abstract | Full Text

Corrigendum

Top

MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy

T-I Hsu, S-C Lin, P-S Lu, W-C Chang, C-Y Hung, Y-M Yeh, W-C Su, P-C Liao and J-J Hung

Oncogene 2017 36: 875-876; advance online publication, August 1, 2016; 10.1038/onc.2016.274

Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group